EP Patent

EP3060143B1 — Maintenance of bronchial patency by local delivery of cytotoxic, cytostatic, or anti-neoplastic agent

Assigned to Mercator MedSystems Inc · Expires 2021-01-06 · 5y expired

What this patent protects

Patent listed against chembl-chembl428647.

Drugs covered by this patent

chembl-chembl428647 (PACLITAXEL)

Patent Metadata

Patent number: EP3060143B1
Jurisdiction: EP
Classification: —
Expires: 2021-01-06
Drug substance claim: No
Drug product claim: No
Assignee: Mercator MedSystems Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.